Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study.

Ainoa UgarteLorena De La MoraElisa De LazzariIván ChiviteEmma FernándezAlexy InciarteMontserrat LagunoJuan AmbrosioniEstela SolbesLeire BerrocalAna González-CordónMaría Martínez-RebollarAlberto FoncillasJúlia CalvoJosé Luis BlancoEsteban MartinezJosep MallolasBerta Torres

Published in: The Journal of antimicrobial chemotherapy (2024)

BIC/FTC/TAF is an optimal treatment for rapid initiation of ART. However, additional strategies to improve retention in care must be implemented.

Keyphrases

antiretroviral therapy
healthcare
loop mediated isothermal amplification
hiv infected
palliative care
quality improvement
mesenchymal stem cells
replacement therapy
health insurance